Robinhood (HOOD) stock climbs modestly as Goldman Sachs lowers price target but keeps Buy rating. January momentum and March event fuel investor interest.
Oil prices dropped over 1% as Trump’s 15% tariff and US-Iran nuclear negotiations impact energy markets. Goldman Sachs upgrades 2026 Brent forecast to $64.
TLDR BitMine purchased 45,759 ETH last week for approximately $90 million, its largest weekly token purchase of 2026 Total holdings now stand at 4.37 million ETH valued…
TLDR Micron Technology is committing $200 billion to U.S. chip production with $50 billion for Boise facilities, $100 billion for Syracuse complex, and $9.6 billion for Japan…
TLDR Michael Burry published a detailed valuation analysis estimating Palantir’s worth at $46 per share with a broad range of $21 to $146. The investor maintains a…
TLDR Sandisk (SNDK) stock has climbed 166% in 2026 on surging AI data center flash memory demand Second-quarter fiscal 2026 revenue increased 61% to $3 billion with…
TLDR Tesla launched Grok AI assistant in UK, Germany, France, and six additional European markets via software update 2026.2.6 for vehicles with AMD Ryzen processors Conversational navigation…
TLDR Medtronic posted Q3 revenue of $9.02 billion and EPS of $1.36, both exceeding Wall Street estimates Shares dropped 2.9% in premarket trading after company maintained fiscal…
TLDR Compass Pathways (CMPS) stock surged 33.7% Tuesday after successful COMP006 Phase 3 trial results for psilocybin-based depression treatment. COMP360 25mg dose achieved -3.8 point MADRS improvement…
TLDR Danaher acquiring Masimo in $9.9 billion deal at $180 per share, representing 38.3% premium Masimo stock jumped 34% Tuesday, tracking toward largest single-day gain in company…
TLDR Citi upgrades outlook on Nvidia with $270 price target, projecting second-half 2026 outperformance driven by B300 and Rubin platform ramp Firm forecasts January-quarter revenue of $67…
TLDR CRISPR Therapeutics (CRSP) stock surged 9.2% Friday following disappointing Q4 results showing $864,000 revenue and $1.37 per share loss. Partner Vertex Pharmaceuticals forecasted $500 million-plus in…
TLDR Figure Technology Solutions (FIGR) forecasts Q4 adjusted net revenue at $155.5M-$160.5M, beating $154.4M consensus estimate Full-year 2025 revenue guidance of $512.5M-$517.5M surpasses analyst expectations of $508.9M…
